344 related articles for article (PubMed ID: 26456195)
1. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
Singh TD; Gupta S; Shrivastav BR; Tiwari PK
Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Downregulation of PTEN in Gallbladder Cancer.
Tekcham DS; Gupta S; Shrivastav BR; Tiwari PK
J Gastrointest Cancer; 2017 Mar; 48(1):110-116. PubMed ID: 28124240
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of
Tekcham DS; Poojary SS; Bhunia S; Barbhuiya MA; Gupta S; Shrivastav BR; Tiwari PK
Indian J Med Res; 2016 May; 143(Supplement):S82-S90. PubMed ID: 27748282
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of subtelomeric methylation and telomere length in gallstone disease and gallbladder cancer patients of North Central India.
Poojary SS; Mishra G; Gupta S; Shrivastav BR; Tiwari PK
J Hepatobiliary Pancreat Sci; 2016 May; 23(5):276-82. PubMed ID: 26856965
[TBL] [Abstract][Full Text] [Related]
5. Significance of methylation status of MASPIN gene and its protein expression in prognosis of gallbladder cancer.
Baghel K; Kazmi HR; Chandra A; Raj S; Srivastava RN
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e120-e125. PubMed ID: 30740890
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic downregulation of desmin in gall bladder cancer reveals its potential role in disease progression.
Bhunia S; Barbhuiya MA; Gupta S; Shrivastava BR; Tiwari PK
Indian J Med Res; 2020 Apr; 151(4):311-318. PubMed ID: 32461394
[TBL] [Abstract][Full Text] [Related]
7. Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease.
Sharma P; Bhunia S; Poojary SS; Tekcham DS; Barbhuiya MA; Gupta S; Shrivastav BR; Tiwari PK
Tumour Biol; 2016 Nov; 37(11):14687-14699. PubMed ID: 27623942
[TBL] [Abstract][Full Text] [Related]
8. Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer.
Brägelmann J; Barahona Ponce C; Marcelain K; Roessler S; Goeppert B; Gallegos I; Colombo A; Sanhueza V; Morales E; Rivera MT; de Toro G; Ortega A; Müller B; Gabler F; Scherer D; Waldenberger M; Reischl E; Boekstegers F; Garate-Calderon V; Umu SU; Rounge TB; Popanda O; Lorenzo Bermejo J
Hepatology; 2021 Jun; 73(6):2293-2310. PubMed ID: 33020926
[TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of maspin mRNA as a predictor of survival in stage II and III gallbladder cancer cases.
Baghel K; Kazmi HR; Raj S; Chandra A; Srivastava RN
Asian Pac J Cancer Prev; 2014; 15(1):343-7. PubMed ID: 24528054
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population.
Bohr UR; Kuester D; Meyer F; Wex T; Stillert M; Csepregi A; Lippert H; Roessner A; Malfertheiner P
Clin Microbiol Infect; 2007 May; 13(5):525-31. PubMed ID: 17346303
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer.
Srivastava A; Pandey SN; Dixit M; Choudhuri G; Mittal B
J Gastroenterol Hepatol; 2008 Jun; 23(6):970-5. PubMed ID: 17944886
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions.
García P; Manterola C; Araya JC; Villaseca M; Guzmán P; Sanhueza A; Thomas M; Alvarez H; Roa JC
Mol Carcinog; 2009 Jan; 48(1):79-89. PubMed ID: 18543280
[TBL] [Abstract][Full Text] [Related]
14. Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer.
Jain K; Mohapatra T; Das P; Misra MC; Gupta SD; Ghosh M; Kabra M; Bansal VK; Kumar S; Sreenivas V; Garg PK
Ann Surg; 2014 Dec; 260(6):1073-80. PubMed ID: 24827397
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation in gallbladder cancer: Promoter methylation profiling as emergent novel biomarkers.
Tekcham DS; Tiwari PK
Asia Pac J Clin Oncol; 2016 Dec; 12(4):332-348. PubMed ID: 27385126
[TBL] [Abstract][Full Text] [Related]
16. Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population.
Rai R; Sharma KL; Misra S; Kumar A; Mittal B
J Cancer Res Clin Oncol; 2014 May; 140(5):725-35. PubMed ID: 24556804
[TBL] [Abstract][Full Text] [Related]
17. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma.
Riquelme E; Tang M; Baez S; Diaz A; Pruyas M; Wistuba II; Corvalan A
Cancer Lett; 2007 May; 250(1):100-6. PubMed ID: 17084965
[TBL] [Abstract][Full Text] [Related]
18. Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer.
Hirosawa T; Ishida M; Ishii K; Kanehara K; Kudo K; Ohnuma S; Kamei T; Motoi F; Naitoh T; Selaru FM; Unno M
PLoS One; 2018; 13(11):e0206643. PubMed ID: 30395583
[TBL] [Abstract][Full Text] [Related]
19. c‑Jun suppresses the expression of WNT inhibitory factor 1 through transcriptional regulation and interaction with DNA methyltransferase 1 in gallbladder cancer.
Lin B; Hong H; Jiang X; Li C; Zhu S; Tang N; Wang X; She F; Chen Y
Mol Med Rep; 2018 Jun; 17(6):8180-8188. PubMed ID: 29693707
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
Igarashi K; Yamashita K; Katoh H; Kojima K; Ooizumi Y; Nishizawa N; Nishiyama R; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Watanabe M
PLoS One; 2017; 12(11):e0188178. PubMed ID: 29161283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
